These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21370412)

  • 1. The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations.
    Brandow AM; Weisman SJ; Panepinto JA
    Pediatr Blood Cancer; 2011 May; 56(5):789-93. PubMed ID: 21370412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
    Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
    Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease.
    Taylor LE; Stotts NA; Humphreys J; Treadwell MJ; Miaskowski C
    J Pain Symptom Manage; 2010 Sep; 40(3):416-35. PubMed ID: 20656451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Healthcare Improvement Initiative to Increase Multidisciplinary Pain Management Referrals for Youth with Sickle Cell Disease.
    Kingsley RA
    Pain Manag Nurs; 2020 Oct; 21(5):403-409. PubMed ID: 32448738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease.
    Dampier C; Ely B; Brodecki D; Coleman C; Aertker L; Sendecki JA; Leiby B; Kesler K; Hyslop T; Stuart M
    Pediatr Blood Cancer; 2014 Feb; 61(2):291-6. PubMed ID: 24115743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
    Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
    Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study.
    Gerardin M; Rousselet M; Couec ML; Masseau A; Guerlais M; Authier N; Deheul S; Roussin A; Micallef J; Djezzar S; ; Feuillet F; Jolliet P; Victorri-Vigneau C
    PLoS One; 2021; 16(3):e0248649. PubMed ID: 33735176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
    Stallworth JR; Jerrell JM; Tripathi A
    Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaso-occlusive painful events in sickle cell disease: impact on child well-being.
    Brandow AM; Brousseau DC; Pajewski NM; Panepinto JA
    Pediatr Blood Cancer; 2010 Jan; 54(1):92-7. PubMed ID: 19653296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keys to Recruiting and Retaining Seriously Ill African Americans With Sickle Cell Disease in Longitudinal Studies: Respectful Engagement and Persistence.
    Suarez ML; Schlaeger JM; Angulo V; Shuey DA; Carrasco J; Roach KL; Ezenwa MO; Yao Y; Wang ZJ; Molokie RE; Wilkie DJ
    Am J Hosp Palliat Care; 2020 Feb; 37(2):123-128. PubMed ID: 31394904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease.
    Kang HA; Barner JC
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1412-1422. PubMed ID: 33119448
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality of life assessments in a cohort of Mozambican children with sickle cell disease.
    Issa F; Dang BN; Buck WC; Chicumbe S; Nicolau N; Virate C; Cassamo N; Dias A; Amodo F
    Pan Afr Med J; 2020; 36():343. PubMed ID: 33224409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report.
    Román ME; Highland J; Retherford D; Pan AY; Panepinto JA; Brandow AM
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28698. PubMed ID: 33034107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home management of pain in sickle cell disease: a daily diary study in children and adolescents.
    Dampier C; Ely E; Brodecki D; O'Neal P
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):643-7. PubMed ID: 12439036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES Project.
    McClish DK; Levenson JL; Penberthy LT; Roseff SD; Bovbjerg VE; Roberts JD; Aisiku IP; Smith WR
    J Womens Health (Larchmt); 2006 Mar; 15(2):146-54. PubMed ID: 16536678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of PROMIS® Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery.
    Dampier C; Jaeger B; Gross HE; Barry V; Edwards L; Lui Y; DeWalt DA; Reeve BB
    Pediatr Blood Cancer; 2016 Jun; 63(6):1038-45. PubMed ID: 26853841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective longitudinal follow-up of children with sickle cell disease treated with hydroxyurea since infancy.
    Thomas R; Dulman R; Lewis A; Notarangelo B; Yang E
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27816. PubMed ID: 31157521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.